STOCK-BASED COMPENSATION (Tables)
|
6 Months Ended |
Jun. 30, 2022 |
Share-based Payment Arrangement [Abstract] |
|
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award |
The following table contains information about the Company's equity incentive plans as of June 30, 2022:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards Reserved for Issuance |
|
Awards Exercised |
|
Awards Outstanding |
|
Awards Available for Grant |
|
|
|
|
|
|
|
|
2016 Equity Incentive Plan |
999,906 |
|
|
— |
|
|
499,953 |
|
|
499,953 |
|
2018 Equity Incentive Plan |
30,988,982 |
|
|
4,022,133 |
|
|
14,009,842 |
|
|
12,957,007 |
|
2019 Equity Incentive Plan |
109,990,468 |
|
|
34,884 |
|
|
73,014,714 |
|
|
36,940,870 |
|
|
Share-based Payment Arrangement, Option, Activity |
The following table summarizes the Company’s stock option activity and related information for the six months ended June 30, 2022:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares
|
|
Weighted- Average Exercise Price Per Share |
|
Weighted- Average Remaining Contractual Life |
|
Aggregate Intrinsic Value of In-the-Money Options |
|
|
|
|
|
|
|
|
Options outstanding as of January 1, 2022 |
88,251,380 |
|
$ |
0.20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted |
400,000 |
|
|
— |
|
|
|
|
|
Exercised |
(146,212) |
|
$ |
0.08 |
|
|
|
|
|
Forfeited |
(223,791) |
|
$ |
0.15 |
|
|
|
|
|
Expired |
(154,762) |
|
$ |
0.34 |
|
|
|
|
|
Options outstanding as of June 30, 2022 |
88,126,615 |
|
$ |
0.20 |
|
|
8.3 years |
|
$ |
33 |
|
Options exercisable as of June 30, 2022 |
50,718,424 |
|
$ |
0.24 |
|
|
7.4 years |
|
$ |
50 |
|
|
Share-based Payment Arrangement, Activity |
The following table sets forth the total stock-based compensation expense resulting from stock options and restricted grants of common stock to employees, directors and non-employee consultants in the consolidated statement of operations which are included in selling, general and administrative expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in thousands except for shares / options) |
|
|
For the Three Months Ended |
|
|
June 30, 2022 |
|
June 30, 2021 |
Type of Award |
|
Number of Shares or Options Granted |
|
Stock-Based Compensation Expense |
|
Number of Shares or Options Granted |
|
Stock-Based Compensation Expense |
|
|
|
|
|
|
|
|
|
Stock options |
|
400,000 |
|
$ |
1,352 |
|
|
5,409,716 |
|
$ |
641 |
|
|
|
|
|
|
|
|
|
|
Stock grants: |
|
|
|
|
|
|
|
|
Employees (common stock) |
|
1,200,000 |
|
|
$ |
170 |
|
|
250,000 |
|
68 |
|
Directors (common stock) |
|
259,796 |
|
$ |
29 |
|
|
343,493 |
|
94 |
|
Non–employee consultants (common stock) |
|
725,000 |
|
$ |
129 |
|
|
— |
|
— |
|
|
|
|
|
|
|
|
|
|
Total stock–based compensation expense |
|
|
|
$ |
1,680
|
|
|
|
|
$ |
803
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in thousands except for shares / options) |
|
|
For the Six Months Ended |
|
|
June 30, 2022 |
|
June 30, 2021 |
Type of Award |
|
Number of Shares or Options Granted |
|
Stock-Based Compensation Expense |
|
Number of Shares or Options Granted |
|
Stock-Based Compensation Expense |
|
|
|
|
|
|
|
|
|
Stock options |
|
400,000 |
|
$ |
3,174 |
|
|
5,909,716 |
|
$ |
885 |
|
|
|
|
|
|
|
|
|
|
Stock grants: |
|
|
|
|
|
|
|
|
Employees (common stock) |
|
2,100,000 |
|
|
$ |
352 |
|
|
250,000 |
|
67 |
|
Directors (common stock) |
|
943,128 |
|
$ |
213 |
|
|
885,159 |
|
214 |
|
Non–employee consultants (common stock) |
|
725,000 |
|
$ |
129 |
|
|
332,947 |
|
32 |
|
|
|
|
|
|
|
|
|
|
Total stock–based compensation expense |
|
|
|
$ |
3,868
|
|
|
|
|
$ |
1,198
|
|
|